Clinical Trial Update: R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating R-ESHAP chemotherapy followed by autologous stem cell transplantation for patients with refractory or relapsed diffuse large B-cell lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• METHYLPREDNISOLONE (methylprednisolone)
• Rituxan (rituximab)

Snippet

Sponsor: Fudan University | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN